Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Zannan and AB Pharma develop novel highly potent HCV NS3/NS4A inhibitor

April 13, 2012

Merck & Co. discovers new potential schizophrenia therapies

April 12, 2012

Amgen reports discovery of novel class of prostanoid EP2 receptor antagonists

April 12, 2012

First-in-human data presented on hypomethylating anticancer agent

April 12, 2012

Tetraphase Pharmaceuticals describes antibacterial activity of novel pentacycline

April 12, 2012

Scientists in U.S. develop new mouse model to study radiation effects

April 12, 2012

New orally bioavailable TTK inhibitor described

April 12, 2012

Novel ApoA-I-mimetic peptide shows promise as atherosclerosis drug

April 11, 2012

Mutant caveolin-1-derived peptide reduces atherosclerotic lesions

April 11, 2012

Takeda reports on efforts to develop new HER2/EGFR kinase inhibitors

April 11, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...